Virus News and Research

Latest Virus News and Research

$4 million program launched to find transformative therapies for ADNP syndrome

Researchers at the UC Davis MIND Institute are launching a $4 million program to find transformative therapies for ADNP syndrome. The rare genetic condition causes developmental delays and can affect the brain, heart, gastrointestinal system and more.

29 Mar 2022

New COVID Recovery Clinic launched by Keck Medicine of USC

Keck Medicine of USC has launched its COVID Recovery Clinic, a multidisciplinary program led by a core team of clinicians specializing in primary care, pulmonology and physical therapy.

29 Mar 2022

FDA approves second COVID-19 booster dose for older and immunocompromised individuals

Today, the U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals.

29 Mar 2022

Penn researchers generate functional CAR T cells with enhanced anti-tumor potency in 24 hours

A new approach from Penn Medicine researchers could cut the time it takes to alter patients' immune cells for infusion back into the body to find and attack cancer.

29 Mar 2022

Government provides new guidance for living with COVID

People at risk of serious illness from COVID-19, and eligible for treatments, will continue to get free tests to use if they develop symptoms, along with NHS and adult social care staff and those in other high-risk settings, Health and Social Care Secretary Sajid Javid announced today (Tuesday 29 March).

29 Mar 2022

The different actions of CBD in SARS-CoV-2 infection

An article has described the role of cannabidiol as a potential inhibitor of hyperinflammation in SARS-CoV-2 infection.

29 Mar 2022

Investigating SARS-CoV-2 detection using Raman microscopy

Researchers investigated the specific intracellular signature of SARS-CoV-2 infection using Raman microscopy.

29 Mar 2022

Study investigates SARS-CoV-2 infection in Swiss stray cats

Recently, researchers surveyed the prevalence of SARS-CoV-2 infection in Swiss stray cats.

29 Mar 2022

Characterization of the different expressed RNAseq variants in SARS-CoV-2 infected patients

A recent study analyzed the RNAseq variants of COVID-19 patients and healthy donors.

29 Mar 2022

Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice

In a new study, researchers tested the bi-, tri-, and tetravalent formulations of Newcastle disease virus (NDV)-based low-cost vaccine in mice.

29 Mar 2022

The relationship between circadian misalignment and the risk of COVID-19 infection

An interesting new study links changes in the daily rhythms of the human body with the risk of COVID-19.

29 Mar 2022

Clinical outcomes of SARS-CoV-2 coinfection with influenza viruses, respiratory syncytial virus, or adenoviruses

A recent paper examines the occurrence of other respiratory viral infections during this period in patients already infected with SARS-CoV-2.

29 Mar 2022

Results of Phase 3 Nanocovax SARS-CoV-2 vaccine trial suggest robust effectiveness

A new study presented the findings of the Phase 3 trial of the Nanocovax coronavirus disease 2019 (COVID-19) vaccine.

29 Mar 2022

Algal metabolites as novel drugs against viruses

A new review article published in the Journal of Biotechnology has provided information on various nutraceutical metabolites extracted from algae.

29 Mar 2022

Is SARS-CoV-2 a Superantigen?

Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), scientists have been conducting extensive studies to understand various aspects of the virus. Researchers have stated that SARS-CoV-2 manifests several biological and clinical consequences of a superantigen

29 Mar 2022

New compound delivered in a nasal spray effectively treats delta variant infection in mice

Researchers have shown a new compound delivered in a nasal spray is highly effective in preventing and treating COVID-19 caused by the Delta variant in mice.

29 Mar 2022

One year after severe COVID-19, T cells persist against SARS-CoV-2

In a recently published article in the journal eBioMedicine, scientists have demonstrated that critically ill coronavirus disease 2019 (COVID-19) patients are capable of generating durable memory T cell response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for more than one year after hospital discharge.

28 Mar 2022

Japanese researchers discover new mechanisms of action by extracellular vesicles in lymphoma

Japanese collaborative research teams have discovered new mechanisms of action by extracellular vesicles (EV) for the development and malignant progression of lymphomas.

28 Mar 2022

Virtual reality helps reduce COVID-19 vaccine hesitancy

A new study investigates whether intention for vaccination is increased by a gamified immersive VR experience that shows how community immunity works.

28 Mar 2022

Northwestern scientists continue to advance the understanding of COVID-19

As the COVID-19 pandemic enters its third year, Northwestern Medicine scientists continue to help advance the understanding of the disease and its impact, from investigating antibody protection against COVID-19 reinfection to elevating women in academic research and highlighting racial and ethnic disparities in COVID-19 hospital mortality in Illinois.

28 Mar 2022

Virus News and Research

Latest Virus News and Research

$4 million program launched to find transformative therapies for ADNP syndrome

New COVID Recovery Clinic launched by Keck Medicine of USC

FDA approves second COVID-19 booster dose for older and immunocompromised individuals

Penn researchers generate functional CAR T cells with enhanced anti-tumor potency in 24 hours

Government provides new guidance for living with COVID

The different actions of CBD in SARS-CoV-2 infection

Investigating SARS-CoV-2 detection using Raman microscopy

Study investigates SARS-CoV-2 infection in Swiss stray cats

Characterization of the different expressed RNAseq variants in SARS-CoV-2 infected patients

Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice

The relationship between circadian misalignment and the risk of COVID-19 infection

Clinical outcomes of SARS-CoV-2 coinfection with influenza viruses, respiratory syncytial virus, or adenoviruses

Results of Phase 3 Nanocovax SARS-CoV-2 vaccine trial suggest robust effectiveness

Algal metabolites as novel drugs against viruses

Is SARS-CoV-2 a Superantigen?

New compound delivered in a nasal spray effectively treats delta variant infection in mice

One year after severe COVID-19, T cells persist against SARS-CoV-2

Japanese researchers discover new mechanisms of action by extracellular vesicles in lymphoma

Virtual reality helps reduce COVID-19 vaccine hesitancy

Northwestern scientists continue to advance the understanding of COVID-19

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in